NCT01877395View on ClinicalTrials.gov

Study of Purified Vero Rabies Vaccine and Rabies Human Diploid Cell Vaccine in a Simulated Rabies Post-exposure Regimen

PHASE2CompletedINTERVENTIONAL

Enrollment

342

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

September 30, 2014

Conditions

Rabies

Interventions

BIOLOGICAL

Purified Vero Rabies Vaccine (VRVg)

0.5 mL, Intramuscular

BIOLOGICAL

Imovax® Rabies: inactivated rabies vaccine

1.0 mL, Intramuscular

Trial Locations (5)

27612

Raleigh

33026

Pembroke Pines

33143

South Miami

59802

Boise

84088

West Jordan

All Listed Sponsors

lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT01877395 - Study of Purified Vero Rabies Vaccine and Rabies Human Diploid Cell Vaccine in a Simulated Rabies Post-exposure Regimen | Biotech Hunter | Biotech Hunter